v3.26.1
Significant Agreements (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Sep. 17, 2025
Jun. 30, 2026
Dec. 31, 2025
Immunovia AB [Member]      
Significant Agreements [Line Items]      
License revenue     $ 0.6
License Agreement [Member]      
Significant Agreements [Line Items]      
Non-refundable upfront license fee $ 0.3    
Payments for study-related services   $ 0.3